M K Proteins
M K Proteins Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for M K Proteins Ltd, framed against the sector median so the premium or discount is obvious at a glance.
M K Proteins Ltd trades at a P/E of 26.44× and P/B of 2.37×, against the Consumer Defensive sector median P/E of 33.74×.
Valuation
Profitability
Growth
Financial Health
M K Proteins Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for M K Proteins Ltd, switchable between annual and quarterly views, consolidated or standalone.
M K Proteins Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹185.81 Cr and reported EPS of ₹0.18.
M K Proteins segment analysis: revenue and profit mix.
Disclosed business segments at M K Proteins with their share of revenue and profit, switchable between consolidated and standalone reporting.
M K Proteins discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
M K Proteins Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy M K Proteins Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
M K Proteins Ltd's investment case rests on 9 positive markers and 9 flagged concerns drawn from the latest reported filings.
What you're getting.
The company exhibits strong promoter confidence with a high promoter holding of 74.82%, indicating that key stakeholders are deeply invested in the company's long-term success and stability.
M K Proteins has demonstrated exceptional quarterly sales growth of 101.00%, reflecting robust demand for its products and effective market penetration strategies.
Profitability is on an upward trend, with quarterly profit after tax increasing by 41.50%, showcasing improved operational efficiency and strong earnings momentum.
The company maintains healthy returns on capital, with an ROE of 12.40% and ROCE of 12.90%, indicating efficient utilization of shareholder funds and overall capital.
A low debt-to-equity ratio of 0.56 suggests a conservative financial structure, providing stability and flexibility for future growth initiatives without excessive leverage.
What can break it.
The stock's P/E ratio of 27.00 appears elevated when compared to some industry peers like Gokul Agro (19.52), potentially indicating an overvaluation in the current market.
M K Proteins currently offers no dividend yield (0.00%), which might make it less attractive to income-seeking investors looking for regular payouts from their investments.
A relatively low Operating Profit Margin (OPM) of 4.36% suggests thin profitability from core operations, making the company vulnerable to cost fluctuations and competitive pressures.
The current stock price of 6.79 is significantly below its 52-week high of 9.78, indicating recent underperformance and a potential lack of investor enthusiasm in the short term.
The absence of FII and DII holdings (0.00%) could signal a lack of institutional investor interest, potentially limiting liquidity and future price appreciation for the stock.
What would change my mind.
Trim if P/E re-rates above 34 (~1.0× the sector multiple of 33.7). The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 49.17. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
M K Proteins Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — M K Proteins Ltd is highlighted for quick read-across.
Quick Compare
M K Proteins Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for M K Proteins Ltd — derived from the live tape, not yesterday's close.
M K Proteins Ltd last traded at ₹4.94 with an intraday range of ₹4.9–₹5.06 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹4.94| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 5.35 | +0.41 | +8.37% |
| R3 | 5.19 | +0.25 | +5.13% |
| R2 | 5.13 | +0.19 | +3.78% |
| R1 | 5.03 | +0.09 | +1.89% |
| PIVOT | 4.97 | 0.03 | 0.54% |
| CURRENT | 4.94 | — | — |
| S1 | 4.55 | -0.39 | -7.83% |
| S2 | 4.71 | -0.23 | -4.59% |
| S3 | 4.81 | -0.13 | -2.70% |
| S4 | 4.87 | -0.07 | -1.35% |
MKPL is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 4.9 ~ 5.06
Trading Inside opening range
M K Proteins Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for M K Proteins Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
M K Proteins Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for M K Proteins Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in M K Proteins Ltd stood at 60.6% of traded volume, against a 20-day average of 75.5%.
M K Proteins announcements: results, concalls, ratings, M&A.
Filings M K Proteins sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
M K Proteins files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 38 documents below.
Disclosure under SEBI Takeover Regulations
Parmod Kumar, Shib Charan Dass Industries Private Ltd, Kamla Finvest Private Ltd, Shree Ganesh Fats Private Ltd has Submitted to the Exchange a copy…
Copy of Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting the copies of Newspaper…
Outcome of Board Meeting
M K Proteins Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, we are submitting herewith copy of Certificate issued by M/s…
Trading Window
M K Proteins Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,…
M K Proteins dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue M K Proteins has declared, sequenced by announce and record date.
M K Proteins corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About M K Proteins Ltd: business, sector, key facts.
What M K Proteins Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
M K Proteins Ltd operates in the Consumer Defensive, listed as NSE: MKPL, BSE: 543919.
M. K. Proteins Limited (MKPL) is primarily engaged in the manufacturing and trading of vegetable refined oils and their associated by-products. Their operations span a wide range of vegetable oils, including rice bran, sunflower, cottonseed, soybean, palm, and canola oils. The company's core business revolves around processing these oils into refined products suitable for various applications, from culinary use to industrial purposes.
A significant aspect of MKPL's business model is the utilization of oil by-products. Instead of discarding these materials, the company processes them into valuable secondary products. This includes extracting and selling rice bran fatty acid oils, rice bran waxes, gums, and spent earth. This vertical integration strategy maximizes resource utilization and contributes to a more efficient and sustainable business operation.
Beyond its refining and processing capabilities, MKPL also plays a crucial role in the import and trade of crude oils. This involvement in the global oil market allows the company to secure raw materials and manage its supply chain effectively. The company's trading activities extend to both edible and non-edible oils, further diversifying its revenue streams and market reach.
In summary, MKPL's business encompasses the entire value chain from sourcing crude oils to refining them, creating valuable by-products, and finally, trading both refined and crude oils in the market. This integrated approach to oil processing and trading positions the company within a robust and diversified market segment within India’s edible oil industry. The company’s focus on utilizing by-products also demonstrates an understanding of sustainable practices and resource management. Established in 2012 and headquartered in Ambala, India, MKPL has carved a niche for itself in the Indian vegetable oil market.
Questions investors ask about M K Proteins Ltd (MKPL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of M K Proteins Ltd (MKPL)?
The current share price of M K Proteins Ltd (MKPL) is ₹4.94. Today, the stock has declined by ₹0.03 (0.60%), trading in a range of ₹4.9 to ₹5.06. The stock opened at ₹5.06 with a trading volume of 1,22,150 shares.
02Is M K Proteins Ltd stock a good investment for long-term?
M K Proteins Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹185.81 crores, P/E ratio of 26.44, ROE of 9.37%, and ROCE of 12.90%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of M K Proteins Ltd stock?
The 52-week high price of M K Proteins Ltd (MKPL) is ₹9.78, while the 52-week low is ₹3.56. Currently trading at ₹4.94, the stock is 22.2% away from its 52-week low and 49.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy M K Proteins Ltd stock at the current price?
Whether to buy M K Proteins Ltd stock at ₹4.94 depends on multiple factors. The stock is currently trading with a P/E ratio of 26.44 and P/B ratio of 2.37. Today's performance shows a loss of 0.60%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of M K Proteins Ltd and when is the next dividend?
M K Proteins Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹4.94, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of M K Proteins Ltd?
M K Proteins Ltd's key financial metrics include: P/E Ratio: 26.44, P/B Ratio: 2.37, ROE: 9.37%, ROCE: 12.90%, Dividend Yield: 0.00%, EPS: ₹0.18, Book Value: ₹2.01, and Debt-to-Equity: 48.67. The company's market cap stands at ₹185.81 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is M K Proteins Ltd stock performing today in the market?
M K Proteins Ltd stock opened at ₹5.06 and is currently trading at ₹4.94, showing a decline of ₹0.03 (0.60%). The intraday high is ₹5.06 and low is ₹4.9. The trading volume stands at 1,22,150 shares, indicating moderate market participation today.
08What is the P/E ratio of M K Proteins Ltd and what does it indicate?
M K Proteins Ltd has a Price-to-Earnings (P/E) ratio of 26.44, which means investors are willing to pay ₹26.44 for every ₹1 of earnings. With an EPS of ₹0.18, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about M K Proteins Ltd (MKPL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AWL Agri Business (AWL) Share PricePeer
- Gokul Refoils and Solvent (GOKUL) Share PricePeer
- Gokul Agro Resources (GOKULAGRO) Share PricePeer
- Kriti Nutrients (KRITINUT) Share PricePeer
- Marico (MARICO) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy